Literature DB >> 19538214

Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study.

A Hietaharju1, H Kuusisto, R Nieminen, K Vuolteenaho, I Elovaara, E Moilanen.   

Abstract

BACKGROUND AND
PURPOSE: The aim of this study was to investigate the levels of three adipocytokines: leptin, adiponectin and adipsin, in serum and cerebrospinal fluid (CSF) of twins discordant for multiple sclerosis (MS). Adipose tissue is an important component connecting immune system and several tissues and organs including CNS. Fat cells produce adipocytokines, which seem to have a role in various autoimmune disorders including MS.
METHODS: Plasma samples were collected from twelve twins and CSF samples from four twins discordant for MS. The concentrations of interleukine (IL)-6, adiponectin, adipsin and leptin in plasma and CSF samples were determined by enzyme immuno assay.
RESULTS: A significant difference was seen in the adipocytokine levels in CSF samples. Twins with MS had higher concentrations of adiponectin (P = 0.039) and adipsin (P = 0.039), than their asymptomatic co-twins.
CONCLUSION: As adiponectin and adipsin levels in CSF did not correlate with their levels in plasma, it seems that there could be a secondary intrathecal synthesis of these adipocytokines in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538214     DOI: 10.1111/j.1468-1331.2009.02701.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

1.  Plasma biomarkers for neuronal ceroid lipofuscinosis.

Authors:  Samantha L Hersrud; Ryan D Geraets; Krystal L Weber; Chun-Hung Chan; David A Pearce
Journal:  FEBS J       Date:  2015-12-17       Impact factor: 5.542

Review 2.  Link between overweight/obese in children and youngsters and occurrence of multiple sclerosis.

Authors:  Thamina Rasul; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

3.  Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients.

Authors:  Riley Bove; Brain C Healy; Alexander Musallam; Pejvak Soltany; Camilo Diaz-Cruz; Neda Sattarnezhad; Bonnie I Glanz; Pia Kivisäkk; Karen K Miller; Tanuja Chitnis
Journal:  Mult Scler       Date:  2018-01-11       Impact factor: 6.312

Review 4.  Adiponectin receptor signalling in the brain.

Authors:  John Thundyil; Dale Pavlovski; Christopher G Sobey; Thiruma V Arumugam
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.

Authors:  Adela Penesova; Miroslav Vlcek; Richard Imrich; Lucia Vernerova; Andrea Marko; Milada Meskova; Lucia Grunnerova; Peter Turcani; Daniela Jezova; Branislav Kollar
Journal:  Metab Brain Dis       Date:  2015-03-27       Impact factor: 3.584

6.  Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.

Authors:  Laura Piccio; Claudia Cantoni; Jacob G Henderson; Daniel Hawiger; Michael Ramsbottom; Robert Mikesell; Jiyoon Ryu; Chyi-Song Hsieh; Viviana Cremasco; Wesley Haynes; Lily Q Dong; Lawrence Chan; Daniela Galimberti; Anne H Cross
Journal:  Eur J Immunol       Date:  2013-06-07       Impact factor: 5.532

7.  Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course.

Authors:  Riley Bove; Elizabeth Secor; Brian C Healy; Alexander Musallam; Timothy Vaughan; Bonnie I Glanz; Emily Greeke; Howard L Weiner; Tanuja Chitnis; Paul Wicks; Philip L De Jager
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

8.  Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.

Authors:  Solaleh Emamgholipour; Seyede Mahdieh Eshaghi; Arash Hossein-nezhad; Khadijeh Mirzaei; Zhila Maghbooli; Mohammad Ali Sahraian
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

9.  Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines.

Authors:  Renuka Natarajan; Sanna Hagman; Mari Hämälainen; Tiina Leppänen; Prasun Dastidar; Eeva Moilanen; Irina Elovaara
Journal:  Mult Scler Int       Date:  2015-11-08

Review 10.  Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity.

Authors:  Mostafa Wanees Ahmed El Husseny; Mediana Mamdouh; Sara Shaban; Abdelrahman Ibrahim Abushouk; Marwa Mostafa Mohamed Zaki; Osama M Ahmed; Mohamed M Abdel-Daim
Journal:  J Diabetes Res       Date:  2017-02-13       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.